XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended
Apr. 05, 2023
Jul. 15, 2022
Jun. 01, 2022
Apr. 13, 2022
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2019
Class of Stock [Line Items]              
Conversion of Stock, Description       The holder will be prohibited from converting shares of Series A Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the shares of common stock then issued and outstanding (provided a holder may elect, at the first closing, to increase such beneficial ownership limitation solely as to itself up to 19.99% of the number of shares of common stock outstanding immediately after giving effect to the conversion, provided further that following the receipt of shareholder approval required by applicable Nasdaq rules with respect to the issuance of common stock that would exceed the beneficial ownership limitation, such beneficial ownership limitation will no longer apply to the holder if the holder notified the Company that the holder wishes the Company to seek such shareholder approval A holder is prohibited from converting shares of Series A Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the shares of our common stock then issued and outstanding (provided a holder may elect, at the first closing, to increase such beneficial ownership limitation solely as to itself up to 19.99% of the number of shares of our common stock outstanding immediately after giving effect to the conversion, provided further that following the receipt of shareholder approval required by applicable Nasdaq rules with respect to the issuance of common stock that would exceed the beneficial ownership limitation, such beneficial ownership limitation will no longer apply to the holder if the holder notified the Company that the holder wishes the Company to seek such shareholder approval).    
Conversion price percentage   140.00%          
Common stock, shares authorized         230,000,000 230,000,000  
Preferred stock no par value         $ 0 $ 0  
Common stock, shares issued         119,278,821 118,643,821  
Common stock, shares outstanding         119,278,821 118,643,821  
Series A preferred stock value $ 1,100,000            
Number of common stock purchase warrants         16,395,343    
Minimum [Member]              
Class of Stock [Line Items]              
Warrant exercise price per share         $ 1.53    
Maximum [Member]              
Class of Stock [Line Items]              
Warrant exercise price per share         $ 5.46    
Common Stock [Member]              
Class of Stock [Line Items]              
Common stock, shares authorized         230,000,000 230,000,000  
Preferred stock no par value         $ 0 $ 0  
Oncocyte Corp [Member]              
Class of Stock [Line Items]              
Ownership percentage             25.00%
Series A Redeemable Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock outstanding percentage       51.00%      
Cash in hand       $ 8,000,000      
Indebtedness expenses       $ 15,000,000      
Dividends rate       6.00%      
Temporary equity, shares issued         5,882.4 6,000  
Temporary equity, shares outstanding         5,882.4 6,000  
Series A Redeemable Convertible Preferred Stock [Member] | Oncocyte Corp [Member] | Preferred Stock [Member]              
Class of Stock [Line Items]              
Ownership percentage       50.00%      
Series A Redeemable Convertible Preferred Stock [Member] | Interest [Member] | Preferred Stock [Member]              
Class of Stock [Line Items]              
Ownership percentage       51.00%      
Series A Redeemable Convertible Preferred Stock [Member] | Security [Member] | Preferred Stock [Member]              
Class of Stock [Line Items]              
Ownership percentage       50.00%      
Series A Redeemable Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]              
Class of Stock [Line Items]              
Offering shares       11,765      
Convertible preferred shares       7,689,542      
Conversion price       $ 1.53      
Preferred stock offering       $ 850      
Stated value per share       $ 1,000      
Gross proceeds, closing       $ 10,000,000      
Net proceeds     $ 10,000,000 4,900,000      
Series A Redeemable Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member] | Share-Based Payment Arrangement, Tranche Two [Member]              
Class of Stock [Line Items]              
Preferred stock offering       $ 5,000,000      
Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Convertible preferred shares       11,765      
Conversion price       $ 1.53      
Gross proceeds, closing       $ 10,000,000      
Preferred stock outstanding percentage       51.00%      
Cash in hand       $ 8,000,000      
Indebtedness expenses       $ 15,000,000      
Temporary equity, shares issued         5,882.4    
Temporary equity, shares outstanding         5,882.4    
Series A Preferred Stock [Member] | Oncocyte Corp [Member]              
Class of Stock [Line Items]              
Equity method investment, description of principal activities   if the daily volume weighted average price of our common stock for 20 out of 30 trading days exceeds 140% of the conversion price and on 20 out of the same 30 trading days the daily trading volume equals or exceeds     if the daily volume weighted average price of our common stock for 20 out of 30 trading days exceeds 140% of the conversion price and on 20 out of the same 30 trading days the daily trading volume equals or exceeds 400,000 shares of our common stock.    
Series A Preferred Stock [Member] | Oncocyte Corp [Member] | Preferred Stock [Member]              
Class of Stock [Line Items]              
Ownership percentage       50.00%      
Series A Preferred Stock [Member] | Security [Member] | Preferred Stock [Member]              
Class of Stock [Line Items]              
Ownership percentage       50.00%      
Series B Preferred Stock [Member] | Registered Direct Offering [Member]              
Class of Stock [Line Items]              
Number of stock redeem 1,064